The innovative new MCD Platform represents a new approach to assay processing and results analysis.  The multiplexed assay has individual target molecules spotted directly into microwells.   MCD operates to ISO 13485, our staff are experienced in FDA 510k applications and we maintain all documentation to enable our collaborators to obtain CE markeing or FDA clearance.  MCD is well equipped to carry out design work, or to use target molecules provided by a 3rd party for use on this system.  

 

The Multiplexed Molecular Processor is fully automated and performs the entire assay from prepared sample to image capture of the completed assay by the integrated camera.  The results data is then transferred and ready for interpretation using our specialist image analysis and interpretation software.  This system is highly flexible and lends itself to many applications including:

 

 

To discuss your application ideas in complete confidence, please contact Peter Maguire

Our Technology